Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap11.9B
Enterprise Value11.61B
P/E Ratio13.15
PEG Ratio0.66
Price/Sales Ratio5.52
Price/Book Ratio4.55
Enterprise/Revenue5.33
Enterprise/EBITDA15.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.29
Operating Margin0.33
AD

Management Effectiveness

Return On Assets0.28
Return On Equity0.39

Income Statement

Revenue2.47B
Revenue/Share10.66
Gross Profit2.01B
EBITDA917.4M
Net Income695.86M
Diluted EPS2.83

Balance Sheet

Total Cash574.03M
Total Cash/Share2.34
Total Debt80.94M
Total Debt/Equity0.04
Current Ratio2.23
Book Value Per Share8.89

Price History

52-Week Change8.09
52-Week High59.07
52-Week Low35.1
Moving Average 50 Days41.46
Moving Average 200 Days47.07

Statistics

Average Volume8.4M
Shares Outstanding357.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.48
Trailing Annual Dividend Yield3.66
Payout Ratio0.23
Last Split Factor29:20
Last Split DateMay 22, 2026
AD